MANE's AI-Powered Sweetener Play Aims to Dominate the Sugar Reduction Market

SEATTLE and LE BAR-SUR-LOUP, France – July 16, 2026 – In a move that signals a seismic shift in the multi-billion-dollar food ingredients market, French flavor and fragrance titan MANE has secured an exclusive global license to produce and commercialize ViaLeaf™ Reb M, a breakthrough sweetener developed by the AI-powered protein design firm Arzeda. The deal hands the 150-year-old, family-owned company full control over the value chain for what may be the most commercially significant sugar-reduction technology to date, positioning MANE to capture a dominant share of the rapidly expanding market for healthy, natural ingredients.

This expanded partnership moves beyond a simple collaboration. By acquiring the rights to manufacture and sell Arzeda’s innovative product, MANE is making a calculated, aggressive play to vertically integrate a next-generation ingredient. This allows the company to move from being a supplier of flavors to a core provider of a foundational food technology, directly addressing the single greatest challenge facing global food and beverage manufacturers: reducing sugar without compromising taste or cost.

The AI-Designed 'Holy Grail' of Sweeteners

For years, the food industry has sought the “holy grail” of sweeteners: a natural, clean-tasting, cost-effective replacement for sugar. Stevia-derived sweeteners have shown promise, but have often been hampered by limitations. While the stevia plant contains several sweet compounds known as steviol glycosides, the most abundant, Reb A, carries a characteristic bitter or licorice-like aftertaste that has limited its application.

Rebaudioside M (Reb M), on the other hand, is widely lauded for its clean, sugar-like profile. The problem? It exists in minute quantities in the stevia leaf—often less than 0.01%—making direct extraction commercially unviable for mass-market products. This has led to a race to develop more efficient production methods, including fermentation and enzymatic conversion.

This is where Arzeda’s technology creates a fundamental disruption. The Seattle-based firm, co-founded by 2024 Nobel Prize in Chemistry winner David Baker, utilizes its “Intelligent Protein Design Technology™” to create novel enzymes with unprecedented efficiency. Using generative AI and a proprietary dataset built over 15 years, Arzeda designs proteins from the ground up to perform specific functions. For ViaLeaf™ Reb M, the company engineered a unique enzyme that efficiently converts abundant stevia compounds into high-purity Reb M.

"What Arzeda has done is solve the economic puzzle of Reb M," noted one industry analyst. "They're not just making a better version of an existing process; their AI-designed enzymes have fundamentally altered the cost structure. This isn't an incremental improvement; it's a step-change in production capability."

This AI-enabled bioconversion process reportedly delivers a superior taste profile while being significantly more cost-effective. According to research, the resulting product is positioned at two-thirds the replacement cost of sugar and can require nearly 50% less volume than Reb A for the same sweetness intensity, a powerful economic incentive for manufacturers.

A Strategic Power Play for a Flavor Giant

For MANE, this deal is far more than an addition to its ingredient portfolio; it's a defining strategic move. By taking full control of production and commercialization, MANE is betting that ViaLeaf™ Reb M will become an industry standard. This allows the company to leverage its immense global scale—spanning 52 R&D centers, 31 production sites, and a sales presence in 41 countries—to rapidly deploy the technology worldwide.

The partnership structure is a model of modern industrial symbiosis: Arzeda, the agile biotech innovator, provides the disruptive, IP-protected technology, while MANE, the established industrial powerhouse, provides the capital, manufacturing expertise, and market access needed for global domination.

Samantha Mane, CEO of the MANE Group, framed the move as a way to deliver a complete package to customers. "By combining Arzeda's breakthrough technology with MANE's production, flavor creation, application, and commercial expertise, we can now offer the market a fully integrated Reb M solution with outstanding taste performance and competitive economics," she stated.

This integration is key. MANE's deep relationships with the world's largest food and beverage companies give it a direct channel to decision-makers who are under immense pressure from consumers and regulators to lower sugar content. By owning the entire process, MANE can guarantee supply, control quality, and manage costs in a way that would be impossible in a more fragmented partnership.

Reshaping the Bottom Line from Lab to Label

The ultimate impact of this partnership will be felt on supermarket shelves and corporate balance sheets. Food and beverage manufacturers now have a viable path to reformulate iconic products—from soft drinks and juices to yogurts and baked goods—to meet clean-label and low-sugar demands without the typical trade-offs.

The announcement comes as consumer demand for healthier options reaches an all-time high. The ability to formulate with a natural, stevia-derived ingredient that performs like sugar is a massive commercial advantage. It allows brands to simplify ingredient lists and appeal to health-conscious shoppers who are increasingly skeptical of artificial sweeteners and complex chemical names.

Alexandre Zanghellini, PhD, CEO of Arzeda, highlighted the significance of the moment, noting that ViaLeaf™ Reb M is the "first ever product enabled by AI-driven protein design to reach the market." He added, "By entrusting MANE with production and commercialization, we are combining Arzeda's innovation capabilities with MANE's global scale and industry leadership to accelerate the adoption of next-generation sweetening solutions worldwide."

This acceleration is the core of the business case. By marrying Nobel Prize-winning science with a 150-year-old manufacturing legacy, the two companies are not just launching a new ingredient. They are establishing a new commercial benchmark for how deep-tech innovation can be rapidly scaled to solve one of the food industry's most persistent and valuable problems.